IGF1 and obesity disorder: Insulin resistance and IGF‐1 signaling are also mechanisms by which obesity affects cancer progression since hyperinsulinemia leads to increased IGF‐1, enhancing tumor cell proliferation and metastasis [107, 108] (Figure 1).